Table 1

Data sets description

General informationData set 1Data set 2Data set 3
Additive solution SAGM AS3 SAGM 
RBC units 20 4 7 
Sex 4 females; 16 males 1 female; 3 males 7 males 
Age (range) 25-58 20-42 22-30 
Blood type 4 0+; 5 A+; 11 B+ 2 0+; 1 A+; 1 AB+ N/A 
Sampling (storage days)     
 Phase 1  Days 1-4-8 Days 2-7 Days 1-8 
 Phase 2  Days 11-15-18 Days 14 Days 15 
 Phase 3  Days 22-25-29-32-36-38-43-46 Days 28-35-42 Days 22-29-36-42 
Samples analyzed     
 Total  n = 280 n = 28 n = 49 
 Phase 1  n = 60 n = 8 n = 14 
 Phase 2  n = 60 n = 4 n = 7 
 Phase 3  n = 160 n = 16 n = 28 
Data analysis performed Biomarkers discovery Biomarkers discovery Biomarkers validation 
General informationData set 1Data set 2Data set 3
Additive solution SAGM AS3 SAGM 
RBC units 20 4 7 
Sex 4 females; 16 males 1 female; 3 males 7 males 
Age (range) 25-58 20-42 22-30 
Blood type 4 0+; 5 A+; 11 B+ 2 0+; 1 A+; 1 AB+ N/A 
Sampling (storage days)     
 Phase 1  Days 1-4-8 Days 2-7 Days 1-8 
 Phase 2  Days 11-15-18 Days 14 Days 15 
 Phase 3  Days 22-25-29-32-36-38-43-46 Days 28-35-42 Days 22-29-36-42 
Samples analyzed     
 Total  n = 280 n = 28 n = 49 
 Phase 1  n = 60 n = 8 n = 14 
 Phase 2  n = 60 n = 4 n = 7 
 Phase 3  n = 160 n = 16 n = 28 
Data analysis performed Biomarkers discovery Biomarkers discovery Biomarkers validation 

N/A, not applicable.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal